SOPHiA GENETICS SA (SOPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

0 7M 14M 21M Q2 '22: 11.7M Q2 '23: 15.1M Q2 '24: 15.8M Q2 '25: 18.3M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Gross Profit Quarterly

0 5M 10M 15M Q2 '22: 7.6M Q2 '23: 10M Q2 '24: 10.8M Q2 '25: 12.3M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Operating Income Quarterly

-27M -18M -9M 0 9M 18M 27M Q2 '22: -24.1M Q2 '23: -20M Q2 '24: -15M Q2 '25: -18.5M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Net Income Quarterly

-27M -18M -9M 0 9M 18M 27M Q2 '22: -24.7M Q2 '23: -21.4M Q2 '24: -15.2M Q2 '25: -22.4M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Cost of Revenue Quarterly

0 2.5M 5M 7.5M Q2 '22: 4M Q2 '23: 5M Q2 '24: 5M Q2 '25: 6.1M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Operating Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '22: 64.1M Q2 '23: 64.5M Q2 '24: 65.9M Q2 '25: 67.3M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.